In conclusion, our research shows that NGF defends neuroblastoma against the cell death triggered by Aβ25–35 via ROS–JNK/c‐Jun suppression through the Nrf2/HO‐1 pathway. The gene discussed is MAPK8; the disease is neuroblastoma.